Nath Bio Genes India Limited Stock Price Today (NSE: NATHBIOGEN)
Fundamental Score
Nath Bio Genes India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nath Bio Genes India Limited share price today is ₹157.68, down 1.99% on NSE/BSE as of 7 August 2026. Nath Bio Genes India Limited (NATHBIOGEN) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹303.57 (Cr). The 52-week high for NATHBIOGEN share price is ₹204.00 and the 52-week low is ₹126.15. At a P/E ratio of 8.38x, NATHBIOGEN is currently trading below its industry average P/E of 19.03x. The company has a Return on Equity (ROE) of 5.47% and a debt-to-equity ratio of 0.20.
Nath Bio Genes India Limited Share Price Chart — NSE/BSE Historical Performance
Nath Bio Genes India Limited share price chart: -3.57% return over the past month. 52-week high ₹204.00, 52-week low ₹126.15.
Nath Bio Genes India Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹164.31 | ₹165.92 | ₹158.20 | ₹160.88 | 48.64K (Cr) | |
| ₹167.00 | ₹167.25 | ₹164.04 | ₹164.75 | 17.80K (Cr) | |
| ₹159.00 | ₹166.99 | ₹159.00 | ₹164.72 | 40.34K (Cr) | |
| ₹160.00 | ₹160.70 | ₹158.60 | ₹158.84 | 9.73K (Cr) | |
| ₹162.50 | ₹164.75 | ₹158.90 | ₹159.18 | 11.82K (Cr) | |
| ₹162.20 | ₹169.90 | ₹160.40 | ₹161.39 | 94.85K (Cr) | |
| ₹163.02 | ₹166.94 | ₹158.00 | ₹159.96 | 12.07K (Cr) | |
| ₹167.00 | ₹167.00 | ₹162.22 | ₹163.88 | 7.72K (Cr) | |
| ₹162.00 | ₹165.90 | ₹162.00 | ₹164.88 | 11.66K (Cr) | |
| ₹159.45 | ₹161.98 | ₹153.61 | ₹161.13 | 19.09K (Cr) |
Nath Bio Genes India Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹160.00 | ₹167.25 | ₹158.20 | ₹160.88 | +0.55% | |
| ₹163.20 | ₹170.00 | ₹153.61 | ₹159.18 | -2.46% | |
| ₹176.08 | ₹180.69 | ₹157.62 | ₹164.77 | -6.42% | |
| ₹196.01 | ₹197.62 | ₹153.63 | ₹175.18 | -10.63% | |
| ₹135.00 | ₹204.00 | ₹133.20 | ₹196.01 | +45.19% | |
| ₹142.01 | ₹150.01 | ₹126.15 | ₹129.02 | -9.15% | |
| ₹147.99 | ₹157.89 | ₹145.25 | ₹150.07 | +1.41% | |
| ₹155.48 | ₹164.99 | ₹136.00 | ₹147.86 | -4.90% | |
| ₹159.75 | ₹163.13 | ₹139.98 | ₹155.49 | -2.67% | |
| ₹175.00 | ₹176.90 | ₹148.01 | ₹156.40 | -10.63% | |
| ₹164.91 | ₹181.90 | ₹161.55 | ₹173.68 | +5.32% | |
| ₹170.83 | ₹179.70 | ₹162.65 | ₹164.91 | -3.47% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Micro-cap seed company with unsustainable earnings; avoid.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Nath Bio-Genes' stock rating was upgraded from Strong Sell to Sell on April 8, 2026, due to technical improvements, despite weak fundamentals. The stock is its 52-week low.
CORE STORY (THE REAL GAME)
Nath Bio-Genes is a play on the Indian hybrid and GM seed market, leveraged to rural agri demand and the vagaries of the monsoon. Not a tech disruptor, but a traditional agri-input company.
- Q3 2026 earnings beat
- Low P/E relative to market
- Short-term outperformance vs Sensex
- Good monsoon
- Government seed subsidies
- New product launches
- Micro-cap liquidity risk
- Weak ROCE
- Erratic monsoons
FII down 0.09%, DII down 1.49% [cite: Brief]
Agri exports are a bright spot for India, but weather remains a key risk.
No Free Cash Flow 5Y [cite: Brief]
Expect continued volatility based on weather patterns and commodity prices. Any sustained rally should be used to exit.
Primary Thesis Risk
Reliance on favorable weather and susceptibility to illegal BT cotton.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nath Bio Genes India Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nath Bio Genes India Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NATHBIOGEN across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (16.80%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 8.38 vs Industry: 19.03)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.20)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹93.98 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Risk Factors
4 factors identified
Below-Average Return on Equity (5.47%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.10%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-101.06%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 0.23%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Nath Bio Genes India Limited vs Other Agricultural Products Peers
Peer Comparison - Other Agricultural Products
Compare Nath Bio Genes India Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Nath Bio Genes India LimitedNath Bio Genes ...Selected✓ NATHBIOGEN • 537291 | 15.3/100 | ₹157.68₹158 | ₹303.57₹303.57 | 8.38Average 8.4 Average | 5.47%Poor 5.47% Poor | 7.10%Poor 7.10% Poor | 0.20Excellent 0.2 Excellent | — — | — — | 1.25% |
LT Foods LtdLT Foods Ltd... LTFOODS • 532783 | 59.6/100 | ₹410.35₹410 | ₹13456.58₹13456.58 | 21.52Average 21.5 Average | 14.94%Average 14.94% Average | 17.74%Good 17.74% Good | 0.36Excellent 0.4 Excellent | 17.99%Excellent 17.99% Excellent | 18.70%Excellent 18.70% Excellent | 0.78% |
KRBL LtdKRBL Ltd... KRBL • 530813 | 45.2/100 | ₹351.10₹351 | ₹8204.32₹8204.32 | 12.66Average 12.7 Average | 11.73%Average 11.73% Average | 15.16%Good 15.16% Good | 0.03Excellent 0.0 Excellent | 3.00%Average 3.00% Average | 8.84%Good 8.84% Good | 0.97% |
Gujarat Ambuja Exports LtdGujarat Ambuja ... GAEL • 524226 | 45.1/100 | ₹172.11₹172 | ₹6852.99₹6852.99 | 22.30Average 22.3 Average | 9.76%Poor 9.76% Poor | 12.51%Average 12.51% Average | 0.13Excellent 0.1 Excellent | -1.98%Poor -1.98% Poor | 4.01%Average 4.01% Average | 0.17% |
Kaveri Seed Company LimitedKaveri Seed Com... KSCL • 532899 | 51.8/100 | ₹782.45₹782 | ₹4345.35₹4345.35 | 14.69Average 14.7 Average | 18.17%Good 18.17% Good | 18.79%Good 18.79% Good | 0.00Excellent 0.0 Excellent | 0.76%Average 0.76% Average | 6.18%Good 6.18% Good | 0.59% |
Sanstar LtdSanstar Ltd... SANSTAR • 544217 | 39.7/100 | ₹111.75₹112 | ₹2204.51₹2204.51 | 63.99Average 64.0 Average | 5.09%Poor 5.09% Poor | 5.69%Poor 5.69% Poor | 0.03Excellent 0.0 Excellent | 19.99%Excellent 19.99% Excellent | 19.85%Excellent 19.85% Excellent | 0.00% |
Grm Overseas LtdGrm Overseas Lt... GRMOVER • 531449 | 40.4/100 | ₹89.73₹90 | ₹1908.68₹1908.68 | 25.67Average 25.7 Average | 14.47%Average 14.47% Average | 13.99%Average 13.99% Average | 0.61Good 0.6 Good | 10.46%Good 10.46% Good | 18.11%Excellent 18.11% Excellent | 0.00% |
Chaman Lal Setia Exp LtdChaman Lal Seti... CLSEL • 530307 | 54.6/100 | ₹285.50₹286 | ₹1389.83₹1389.83 | 12.11Average 12.1 Average | 14.61%Average 14.61% Average | 18.32%Good 18.32% Good | 0.10Excellent 0.1 Excellent | 6.95%Good 6.95% Good | 11.07%Good 11.07% Good | 0.89% |
Gulshan Polyols LtdGulshan Polyols... GULPOLY • 532457 | 58.1/100 | ₹197.32₹197 | ₹1131.69₹1131.69 | 10.55Average 10.6 Average | 16.11%Good 16.11% Good | 18.31%Good 18.31% Good | 0.44Excellent 0.4 Excellent | 11.71%Good 11.71% Good | 24.73%Excellent 24.73% Excellent | 0.17% |
Avt Natural Products LtdAvt Natural Pro... AVTNPL • 519105 | 58.2/100 | ₹71.47₹71 | ₹1079.35₹1079.35 | 16.65Average 16.6 Average | 12.16%Average 12.16% Average | 14.22%Average 14.22% Average | 0.20Excellent 0.2 Excellent | 7.57%Good 7.57% Good | 8.01%Good 8.01% Good | 1.13% |
53.4/100 | ₹85.00₹85 | ₹901.37₹901.37 | 33.81Average 33.8 Average | 22.62%Excellent 22.62% Excellent | 15.97%Good 15.97% Good | 0.83Good 0.8 Good | 35.95%Excellent 35.95% Excellent | 15.04%Excellent 15.04% Excellent | 0.00% | |
Top Other Agricultural Products Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- LT Foods Ltd share price13456.58 Cr
- KRBL Ltd share price8204.32 Cr
- Gujarat Ambuja Exports Ltd share price6852.99 Cr
- Kaveri Seed Company Limited share price4345.35 Cr
- Sanstar Ltd share price2204.51 Cr
Nath Bio Genes India Limited PE Ratio History
Historical price-to-earnings ratio for NATHBIOGEN — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹20.14 | ₹155.49 | 7.7x |
| FY 2024 | ₹21.34 | ₹186.56 | 8.7x |
| FY 2023 | ₹18.43 | ₹207.40 | 11.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nath Bio Genes India Limited Dividend History
Annual cash dividends paid by NATHBIOGEN — dividend yield 1.25%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.80 Cr |
| FY 2024 | ₹3.80 Cr |
| FY 2023 | ₹3.80 Cr |
| FY 2022 | ₹3.80 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Nath Bio Genes India Limited Quarterly Performance
Latest quarterly metrics for NATHBIOGEN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-0.73%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-101.06%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Nath Bio Genes India Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NATHBIOGEN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nath Bio Genes India Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nath Bio Genes India Limited (NATHBIOGEN) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Nath Bio Genes India Limited
About NATHBIOGEN (Nath Bio Genes India Limited)
Nath Bio-Genes India Limited is a pioneering force in the realm of Indian agricultural innovation, focusing on developing and distributing cutting-edge solutions for enhancing crop... yields and promoting sustainable farming practices. The company is dedicated to researching, producing, and marketing a diverse portfolio of high-quality agricultural products beyond conventional seeds. These include bio-stimulants, soil conditioners, and crop protection agents, all designed to work synergistically with traditional farming methods to improve plant health and resilience. NATHBIOGEN aims to empower farmers with the tools and knowledge they need to maximize productivity while minimizing their environmental footprint, fostering a future where agriculture is both efficient and environmentally responsible. Beyond seeds, NATHBIOGEN is invested in the development of advanced agricultural technologies aimed at optimizing resource utilization and reducing crop losses. This includes precision farming solutions like drone-based crop monitoring and data-driven irrigation management systems. By leveraging the power of technology, NATHBIOGEN seeks to provide farmers with real-time insights into crop health, enabling them to make informed decisions about planting, fertilization, and pest control. This proactive approach to agriculture not only boosts crop yields but also minimizes the use of water, fertilizers, and pesticides, contributing to a more sustainable and environmentally friendly farming ecosystem. The company understands agriculture's ever-evolving landscape, and is actively exploring sustainable and regenerative agriculture practices to protect farmland. At the heart of NATHBIOGEN's operations is a deep commitment to farmer education and support. The company recognizes that simply providing innovative products is not enough; farmers need to understand how to effectively use these tools to achieve optimal results. To this end, NATHBIOGEN invests heavily in training programs, field demonstrations, and advisory services, ensuring that farmers have access to the knowledge and expertise they need to succeed. By building strong relationships with farmers and providing ongoing support, NATHBIOGEN aims to create a collaborative ecosystem where innovation and practical knowledge converge to drive sustainable agricultural growth and improve the livelihoods of farming communities across India and beyond.
Company Details
Key Leadership
Corporate Events
NATHBIOGEN Share Price: Frequently Asked Questions
What is the current share price of Nath Bio Genes India Limited?
Nath Bio Genes India Limited (NATHBIOGEN) trades at ₹157.68 on NSE and BSE. Market cap ₹303.57 (Cr). Educational data only.
What is the P/E ratio of Nath Bio Genes India Limited?
Nath Bio Genes India Limited has a P/E of 8.38x vs industry average 19.03x.
What is the Bull Run score for Nath Bio Genes India Limited?
Nath Bio Genes India Limited has a Bull Run score of 15.3/100 based on 25+ financial parameters.
Does Nath Bio Genes India Limited pay dividends?
Nath Bio Genes India Limited has a dividend yield of 1.25%. Past dividends don't guarantee future payments.
What is the ROE of Nath Bio Genes India Limited?
Nath Bio Genes India Limited has ROE of 5.47%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nath Bio Genes India Limited?
Nath Bio Genes India Limited has debt-to-equity of 0.20.
Is Nath Bio Genes India Limited a good investment?
Bull Run gives Nath Bio Genes India Limited a score of 15.3/100. This is not investment advice — consult a SEBI-registered advisor.